Will Mylan Crush Teva’s Generic Dreams?
November 06, 2017 at 14:27 PM EST
Bad news may be baked into shares of drug makers Mylan and Teva even as a new generic poses a pricing challenge.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|